2014
DOI: 10.4103/0253-7613.129318
|View full text |Cite
|
Sign up to set email alerts
|

Population pharmacokinetics of bupivacaine in combined lumbar and sciatic nerve block

Abstract: Objectives:The primary aim of this study was to establish the population pharmacokinetic (PPK) model of bupivacaine after combined lumbar plexus and sciatic nerve blocks and secondary aim is to assess the effect of patient's characteristics including age, body weight and sex on pharmacokinetic parameters.Materials and Methods:A total of 31 patients scheduled for elective lower extremity surgery with combined lumbar and sciatic nerve block using plain bupivacaine 0.5% were included. The total bupivacaine plasma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…However, numerous studies report severe cardiovascular toxicity induced by bupivacaine [ 27 ]. Although ropivacaine and levobupivacaine may present a more reliable alternative to bupivacaine, its use is still widespread because it provides a more lasting effect [ 28 ]. Moreover, in Morocco, bupivacaine and lidocaine remain the only products used for locoregional analgesia in adults, mainly for financial reasons.…”
Section: Discussionmentioning
confidence: 99%
“…However, numerous studies report severe cardiovascular toxicity induced by bupivacaine [ 27 ]. Although ropivacaine and levobupivacaine may present a more reliable alternative to bupivacaine, its use is still widespread because it provides a more lasting effect [ 28 ]. Moreover, in Morocco, bupivacaine and lidocaine remain the only products used for locoregional analgesia in adults, mainly for financial reasons.…”
Section: Discussionmentioning
confidence: 99%